Expression pattern of MRPS18 family genes in medulloblastoma: a case report




embryonal tumors, medulloblastoma, MRPS18 family genes, proteins MRPS18-1, MRPS18-2 and MRPS18-3, RB gene, RB protein


Medulloblastoma is one of the most prevalent brain tumors in children. Due to alterations in the gene expression patterns, medulloblastomas display diversity in the transcriptional, genetic, and clinical markers. However, these markers are few. Hence, there is an urgent need for other molecular, preferentially, non-invasive markers to propose the personalized treatment. One of the putative markers can be the mitochondrial ribosomal protein MRPS18-2.

Purpose: In the present work we aimed to study expression of the MRPS18 family genes at mRNA and protein levels, in serum and tissue of the medulloblastoma. 

Materials and methods. To do so, a real-time quantitative polymerase chain reaction (qPCR) was used to assess the relative expression of RB and MRPS18 family genes at mRNA levels in patient sera and tissue. Protein signals were detected by immunohistochemistry. The relative expression of MRPS18 genes was lower, when assessed in serum of the tumor patient compared with the control.

Results. Thus, MRPS18-1 expression level, detected in serum, is up to 8.5-folds lower than in the control sample, while in tissue it is quite similar in both samples. The MRPS18-2 gene was detected at up to 26-fold lower levels in the serum of the tumor patient. Importantly, MRPS18-2 and MRPS18-3 are elevated by 13- and 7.2-fold, respectively, in tumor tissue, compared to the control. Moreover, the MRPS18-2 protein signal is dramatically elevated in medulloblastoma cells, compared with the conditionally healthy brain tissue.

Concluding, the members of the MRPS18 protein family, especially MRPS18-2, are the putative candidates for molecular prognostic markers. More experiments should be done on a study on this family, and on a large cohort.

Author Biographies

Larysa M. Kovalevska , RE Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, Kyiv

Laboratory of Molecular Mechanisms of Cells Transformation 

Valeriia M. Shcherbina, RE Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, Kyiv

Laboratory of Molecular Mechanisms of Cells Transformation

Serhii S. Kalman , RE Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, Kyiv

Laboratory of Molecular Mechanisms of Cells Transformation

Ludmila M. Verbova, Romodanov Neurosurgery Institute, Kyiv

Department of Pediatric Neurosurgery

Volodymyr D. Rozumenko, Romodanov Neurosurgery Institute, Kyiv

Intracerebral Tumors Department

Tetyana A. Malysheva, Romodanov Neurosurgery Institute, Kyiv

Neuropathomorphology Department

Elena V. Kashuba, Karolinska Institutet, Stockholm

Department of Microbiology, Tumor and Cell Biology (MTC)


Zozulya YA, Orlov YA. [The concept of pediatrics neurosurgery development in Ukraine from 2010 to 2015]. Ukrainian Neurosurgical Journal. 2010;(1):66-73. Ukrainian. doi: 10.25305/unj.88779

Ostrom QT, Patil N, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017. Neuro Oncol. 2020 Oct 30;22(12 Suppl 2):iv1-iv96. doi: 10.1093/neuonc/noaa200

Miller KD, Ostrom QT, Kruchko C, Patil N, Tihan T, Cioffi G, Fuchs HE, Waite KA, Jemal A, Siegel RL, Barnholtz-Sloan JS. Brain and other central nervous system tumor statistics, 2021. CA Cancer J Clin. 2021 Sep;71(5):381-406. doi: 10.3322/caac.21693

Khan M, Wong K, Jardel D, Broggio J, Stiller C, McCabe M. Medulloblastoma incidence and survival-A Population Based Study. Neuro Oncol. 2018 Oct;20 (Suppl 5):v350-1. doi: 10.1093/neuonc/noy129.030

Weil AG, Wang AC, Westwick HJ, Ibrahim GM, Ariani RT, Crevier L, Perreault S, Davidson T, Tseng CH, Fallah A. Survival in pediatric medulloblastoma: a population-based observational study to improve prognostication. J Neurooncol. 2017 Mar;132(1):99-107. doi: 10.1007/s11060-016-2341-4

Orr BA. Pathology, diagnostics, and classification of medulloblastoma. Brain Pathol. 2020 May;30(3):664-678. doi: 10.1111/bpa.12837

Chernenko OG. [Features of continued growth and metastasis of cerebellar medulloblastoma]. Ukrainian Neurosurgical Journal. 2007;(2):29-36. Ukrainian. doi: 10.25305/unj.130680

Quinlan A, Rizzolo D. Understanding medulloblastoma. JAAPA. 2017 Oct;30(10):30-36. doi: 10.1097/01.JAA.0000524717.71084.50

Hoshide R, Jandial R. 2016 World Health Organization Classification of Central Nervous System Tumors: An Era of Molecular Biology. World Neurosurg. 2016 Oct;94:561-562. doi: 10.1016/j.wneu.2016.07.082

Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021 Aug 2;23(8):1231-1251. doi: 10.1093/neuonc/noab106

Northcott PA, Buchhalter I, Morrissy AS, Hovestadt V, Weischenfeldt J, Ehrenberger T, et al. The whole-genome landscape of medulloblastoma subtypes. Nature. 2017 Jul 19;547(7663):311-317. doi: 10.1038/nature22973

Cavalli FMG, Remke M, Rampasek L, Peacock J, Shih DJH, Luu B, et al. Intertumoral Heterogeneity within Medulloblastoma Subgroups. Cancer Cell. 2017 Jun 12;31(6):737-754.e6. doi: 10.1016/j.ccell.2017.05.005

Morrissy AS, Cavalli FMG, Remke M, Ramaswamy V, Shih DJH, Holgado BL, et al. Spatial heterogeneity in medulloblastoma. Nat Genet. 2017; 49(5): 780-788. doi: 10.1038/ng.3838

Kashuba E, Mushtaq M. Do MRPS18-2 and RB proteins cooperate to control cell stemness and differentiation, preventing cancer development? Exp Oncol. 2017 Mar;39(1):12-16. doi: 10.31768/2312-8852.2017.39(1):12-16

Mushtaq M, Kovalevska L, Darekar S, Abramsson A, Zetterberg H, Kashuba V, Klein G, Arsenian-Henriksson M, Kashuba E. Cell stemness is maintained upon concurrent expression of RB and the mitochondrial ribosomal protein S18-2. Proc Natl Acad Sci U S A. 2020 Jul 7;117(27):15673-15683. doi: 10.1073/pnas.1922535117

Mints M, Mushtaq M, Iurchenko N, Kovalevska L, Stip MC, Budnikova D, Andersson S, Polischuk L, Buchynska L, Kashuba E. Mitochondrial ribosomal protein S18-2 is highly expressed in endometrial cancers along with free E2F1. Oncotarget. 2016 Apr 19;7(16):22150-8. doi: 10.18632/oncotarget.7905

Mushtaq M, Ali RH, Kashuba V, Klein G, Kashuba E. S18 family of mitochondrial ribosomal proteins: evolutionary history and Gly132 polymorphism in colon carcinoma. Oncotarget. 2016 Aug 23;7(34):55649-55662. doi: 10.18632/oncotarget.10957



How to Cite

Kovalevska , L. M. ., Shcherbina, V. M. ., Kalman , S. S., Verbova, L. M., Rozumenko, V. D., Malysheva, T. A., & Kashuba, E. V. (2022). Expression pattern of MRPS18 family genes in medulloblastoma: a case report. Ukrainian Neurosurgical Journal, 28(4), 35–40.



Original articles